Blood Pressure

Both lower HbA1c and lower blood pressure were protective cardiovascular health metrics for adults with type 1 diabetes, according to findings published in Diabetologia.

In patients with CV risks, there was a correlation between acetaminophen use and elevated systolic BP, according to a meta-analysis in the European Journal of Preventive Cardiology.

People with type 2 diabetes who achieved recommended targets for HbA1c, systolic blood pressure, LDL cholesterol and BMI had increased life expectancy, although the size of increase differed among the biomarkers, concluded recent research.

In recognition of World Hypertension Day, Healio and Cardiology Today have compiled a list of recent updates in hypertension research and management.

WASHINGTON — Childhood risk factors and the change in combined-risk z score between childhood and adulthood were associated with CV events in midlife, researchers reported.

Vivalink announced the availability of the first multimodal wearable patch for remote BP monitoring for use in commercial research and development.

The expanded indication for BP-lowering treatment by the 2021 Kidney Disease: Improving Global Outcomes guideline affects more than 10% of patients with chronic kidney disease, who are at higher CVD risk than those with well-controlled BP.

In the phase 2 SEISMiC trial, istaroxime met its primary endpoint of improving systolic BP profile at 6 hours in patients with cardiogenic shock, according to the topline results announced by Windtree Therapeutics.

BOSTON — In a review of the Kidney Disease: Improving Global Outcomes recommendations, a speaker discussed the Kidney Disease Outcomes Quality Initiative commentary on the updated guidelines here.

WASHINGTON — Most hypertension-related information available on the social media platform TikTok is not presented by health care professionals and often contains recommendations not backed by scientific evidence, researchers reported.